Table 1.
Demographics and Clinical Characteristics of 252 Solitary Papillary Thyroid Carcinoma Patients
| Characteristics | Results (%) |
|---|---|
| No. of patients | 252 |
| Sex | |
| Male | 76(30.2) |
| Female | 176(69.8) |
| Age (mean and range) | 39.6 ± 11.9 (12 to 72) |
| ≥55 | 23(9.1) |
| ˂55 | 229(90.9) |
| BRAFV600E mutation | 188(74.6) |
| TSH levels | |
| Low | 6(2.4) |
| Normal | 209(82.9) |
| High | 37(14.7) |
| Lymphocytic thyroiditis | 89(35.3) |
| Tumor size (cm, mean) | 1.981 ± 1.246 |
| ≥1.0 | 212(84.1) |
| ˂1.0 | 40(15.9) |
| Calcification of the tumor on neck US | 233(92.5) |
| Multifocality | |
| Yes/No | 125(49.6)/127(50.4) |
| Bilaterally | |
| Yes/No | 91(36.1)/161(63.9) |
| Capsule invasion | 69(27.4) |
| CLNM (mean) | 205(81.3)/(4.286 ± 4.524) |
| Ipsilateral | 204(80.9) |
| Contralateral | 24(9.5) |
| Bilateral | 55(21.8) |
| LLNM | 208(82.5) |
| Level II | 89(42.8) |
| Level III | 148(71.2) |
| Level IV | 177(85.1) |
| Level V | 37(17.8) |
Abbreviations: TSH, thyroid-stimulating hormone; US, ultrasonography; CLNM, central lymph node metastases; LLNM, lateral lymph node metastasis.